The declining share of U.S. doctors in adult primary care is about 25% — a point beyond which many Americans won’t be able to find a family doctor at all.
Brand-name drug prices in the U.S. — more than three times the price in other developed countries — are related neither to the amount of research and development required to bring them to market nor their therapeutic value, recent research shows. Have drugmakers overplayed their hand?
Sin barreras, los precios de algunos medicamentos existentes se han disparado, incluso cuando han caído drásticamente en otros países. Los nuevos medicamentos tienen precios enormes, respaldados por el lobby y el marketing.
After decades of unchecked mergers, health care is the land of giants, with huge medical systems monopolizing care in many cities, states, and even whole regions of the country. This decreases patient choice, impedes innovation, erodes quality of care, and raises prices. And federal regulators have been slow to act.
The Department of Health and Human Services is tasked with monitoring denials both by Obamacare health plans and those offered through employers and insurers. As insurers’ denials become more common, they sometimes defy not just medical standards of care but sheer logic. Why hasn’t the agency fulfilled its assignment?
Given a dire shortage of human behavioral health providers in the U.S., it may prove tempting for insurers to offer up apps and chatbots to meet the federal mental health parity requirement. But artificial intelligence, by definition fake, can’t master the empathic flow between patient and doctor that’s central to therapy.
Today’s public service announcements on gun safety feel somewhat sanitized. It’s time to act with the same kind of visceral public campaign that helped de-glorify smoking. Would filmmakers commit to making action movies without guns, just as filmmakers stopped making smoking glamorous in films?
With fears of a winter surge looming, government agencies have authorized and encouraged vaccination with a newly formulated booster. But the science to support that decision remains inconclusive.
The federal government is stepping in to assist student loan borrowers. But little public attention has been focused on what is — statistically, at least — a bigger, broader debt crisis in our country: An estimated 100 million people in the U.S., or 41% of all adults, are saddled with pernicious health care debt.
Poca atención pública se ha centrado en lo que es, al menos estadísticamente, una crisis de deuda más grande: se estima que 100 millones de personas, o el 41% de todos los adultos del país, tienen deudas de atención médica, en comparación con 42 millones con deuda estudiantil.